Home/Accession Therapeutics/Bent Jakobsen, PhD, FMedSci
BJ

Bent Jakobsen, PhD, FMedSci

CEO

Accession Therapeutics

Therapeutic Areas

Accession Therapeutics Pipeline

DrugIndicationPhase
TROCEPT-01 (ATTR-01)Solid CancersPhase 1
TROCEPT-02 (ATTR-02)Not SpecifiedPreclinical